CE certification for med·wave®
Neuranix is proud to announce to have obtained the CE certification for med·wave® as a class IIa medical device in accordance with Regulation 745/2017 (MDR-Medical
Neuranix at EUHA 2022 – 66th International EUHA Congress from October 12 to 14, 2022 in Hanover, Germany
We are glad to share that Neuranix was there in Hannover to present the PLAI® (Pressure Less Acoustic Immittance) methodology for the first time in
Neuranix announces a new completed capital injection and a reinforced shareholder structure
We are proud to announce that after a long period of intense R&D, product testing and the launch of our first PLAI™ based devices in
Neuranix receives a €120.000 grant
Within the POR – “Investment for growth and employment” objective FESR part European Regional Development Fund 2014-2020 ASSE Axis 1 ACTION 1.4.1. “Call for grants
Neuranix Srl
Neuranix receives financial support from Invitalia, Ministry of Economic Development Development of a diagnostic device for the clinical-audiometric investigation of middle ear pathologies. a subsidized
